Effect of saccharin on albino rats' blood indices and the therapeutic action of vitamins C and E.
The present work aimed to study some blood indices of rats as affected by saccharin and the therapeutic action of vitamins C and E. The used adult female Rattus norvegicus albino rats in the present study were weighing 100-120 g. Administration of saccharin at a dose of 35 mg kg⁻¹ body weight (b.wt.) day⁻¹ for 35 days significantly decreased serum glucose, triglycerides, cholesterol, total protein and albumin values. These decrements were by 20.16%, 22.76%, 44.92%, 20.16% and 40.44%, respectively, compared to control level (p value < 0.01). But it increased levels of kidney function indices. The effect of saccharin was more pronounced on creatinine. Activities of Alanine aminotranferease (ALT), aspartate aminotransferase (AST) and Alkaline phosphatase (ALP) increased significantly following saccharin treatment to rats. Concerning hematoligical parameters, the more obvious changes were observed in the increment of white blood cell (WBC), mean corpuscular volume (MCV) and platelets (PLT) and the decrease in hematocrit, hemoglobin (Hb) and red blood cells (RBCs) count in response to the administration of saccharin. In general, vitamin C or E (150 mg kg⁻¹ b.wt. day⁻¹ for 35 days) was able to reduce the effects of saccharin intake. Both vitamins, however, generally have beneficial effects in reducing the changes in the studied parameters.
Abdelaziz
Ismael
I
Biology Department, Faculty of Science, the Islamic University of Gaza, Palestine.
Ashour
Abd El Rahiem A
Ael R
D000818:Animals; D000975:Antioxidants / Q000008:administration & dosage / Q000627:therapeutic use*; D001205:Ascorbic Acid / Q000008:administration & dosage / Q000627:therapeutic use*; D001774:Blood Chemical Analysis; D064420:Drug-Related Side Effects and Adverse Reactions / Q000097:blood* / Q000139:chemically induced / Q000517:prevention & control; D005260:Female; D006403:Hematologic Tests; D051381:Rats; D012439:Saccharin / Q000633:toxicity*; D013549:Sweetening Agents / Q000633:toxicity*; D014810:Vitamin E / Q000008:administration & dosage / Q000627:therapeutic use*
D000975:Antioxidants; D013549:Sweetening Agents; D014810:Vitamin E; D012439:Saccharin; D001205:Ascorbic Acid